Paper28650
Salazopyrin in rheumatoid arthritis.
McConkey B and 5 others. Agents Actions, 1978. Cited by 91 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Salazopyrin in rheumatoid arthritis. Papers, record 28650. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28650
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Arthritis, Rheumatoid | Major topic |
| Sulfasalazine | Major topic |
| Blood Sedimentation | |
| C-Reactive Protein | |
| Female | |
| Humans | |
| Male | |
| Middle Aged |
Source PubMed
References12
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4,561,431 | The assessment of rheumatoid arthritis. A study based on measurements of the serum acute-phase reactants. | Q J Med | 1972 | https://conductscience.org/library/papers/4561431 | PubMed |
| 2 | 4,116,086 | Pathology, pathogenesis, and aetiology of rheumatoid arthritis. | Ann Rheum Dis | 1972 | https://conductscience.org/library/papers/4116086 | PubMed |
| 3 | 4,146,086 | Pharmacokinetics and azo-link cleavage of salazopyrine in man. | Gut | 1973 | https://conductscience.org/library/papers/4146086 | PubMed |
| 5 | 21,720 | Further studies of sulphasalazine metabolism in the treatment of ulcerative colitis. | Br Med J | 1977 | https://conductscience.org/library/papers/21720 | PubMed |
| 6 | 788,118 | Dapsone in rheumatoid arthritis. | Rheumatol Rehabil | 1976 | https://conductscience.org/library/papers/788118 | PubMed |
| 7 | 74,460 | Multiple immune complexes and hypocomplementaemia in dermatitis herpetiformis and coeliac disease. | Lancet | 1976 | https://conductscience.org/library/papers/74460 | PubMed |
| 9 | 647,307 | Rheumatoid arthritis: C-reactive protein and erythrocyte sedimentation rate during initial treatment. | Br Med J | 1978 | https://conductscience.org/library/papers/647307 | PubMed |
| 10 | 14,466,713 | Sulfapyridine and sulfone type drugs in dermatology. | Arch Dermatol | 1962 | https://conductscience.org/library/papers/14466713 | PubMed |
| 11 | 832,072 | Rheumatoid arthritis: relation of serum C-reactive protein and erythrocyte sedimentation rates to radiographic changes. | Br Med J | 1977 | https://conductscience.org/library/papers/832072 | PubMed |
| 14 | 17,446 | Megaloblastic anaemia associated with sulphasalazine treatment. | Br Med J | 1977 | https://conductscience.org/library/papers/17446 | PubMed |
| 15 | 14,238,065 | COMPARISON OF ACETARSOL AND PREDNISOLONE-21-PHOSPHATE SUPPOSITORIES IN THE TREATMENT OF IDIOPATHIC PROCTITIS. | Lancet | 1965 | https://conductscience.org/library/papers/14238065 | PubMed |
| 16 | 4,370,457 | The effects of some anti-inflammatory drugs on the acute-phase proteins in rheumatoid arthritis. | Q J Med | 1973 | https://conductscience.org/library/papers/4370457 | PubMed |
Cited by28
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 91 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37,431,434 | Discontinuation rate of sulfasalazine, leflunomide and methotrexate due to adverse events in a real-life setting (NOR-DMARD). | Rheumatol Adv Pract | 2023 | https://conductscience.org/library/papers/37431434 | PubMed |
| 31,831,878 | Drug repurposing to improve treatment of rheumatic autoimmune inflammatory diseases. | Nat Rev Rheumatol | 2020 | https://conductscience.org/library/papers/31831878 | PubMed |
| 18,475,455 | Mechanism of action of 5-arninosalicylic acid. | Mediators Inflamm | 1992 | https://conductscience.org/library/papers/18475455 | PubMed |
| 11,945,114 | Safety and efficacy of disease-modifying anti-rheumatic agents: focus on the benefits and risks of etanercept. | Drug Saf | 2002 | https://conductscience.org/library/papers/11945114 | PubMed |
| 10,796,400 | Sulfasalazine for rheumatoid arthritis. | Cochrane Database Syst Rev | 2000 | https://conductscience.org/library/papers/10796400 | PubMed |
| 7,588,084 | Sulfasalazine. A review of its pharmacological properties and therapeutic efficacy in the treatment of rheumatoid arthritis. | Drugs | 1995 | https://conductscience.org/library/papers/7588084 | PubMed |
| 7,363,012 | Polypharmacy in rheumatic diseases. | Br Med J | 1980 | https://conductscience.org/library/papers/7363012 | PubMed |
| 6,142,116 | Sulphasalazine in rheumatoid arthritis: an old drug revived. | J R Soc Med | 1984 | https://conductscience.org/library/papers/6142116 | PubMed |
| 6,138,117 | Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate. | Br Med J (Clin Res Ed) | 1983 | https://conductscience.org/library/papers/6138117 | PubMed |
| 6,138,116 | Comparison between penicillamine and sulphasalazine in rheumatoid arthritis: Leeds-Birmingham trial. | Br Med J (Clin Res Ed) | 1983 | https://conductscience.org/library/papers/6138116 | PubMed |
| 6,106,520 | Do drugs change the course of rheumatoid arthritis? | Br Med J | 1980 | https://conductscience.org/library/papers/6106520 | PubMed |
| 6,102,877 | Sulphasalazine in rheumatoid arthritis. | Br Med J | 1980 | https://conductscience.org/library/papers/6102877 | PubMed |
| 3,284,488 | Co-trimoxazole in rheumatoid arthritis: a comparison with sulphapyridine. | Ann Rheum Dis | 1988 | https://conductscience.org/library/papers/3284488 | PubMed |
| 2,901,303 | Sulphasalazine in rheumatoid arthritis: combination therapy with D-penicillamine or sodium aurothiomalate. | Clin Rheumatol | 1988 | https://conductscience.org/library/papers/2901303 | PubMed |
| 2,894,913 | Sulphasalazine in arthritis--an old drug rediscovered. | Clin Rheumatol | 1987 | https://conductscience.org/library/papers/2894913 | PubMed |
| 2,883,940 | Sulphasalazine and regression of rheumatoid nodules. | Ann Rheum Dis | 1987 | https://conductscience.org/library/papers/2883940 | PubMed |
| 2,877,858 | Sulphasalazine in the long term management of rheumatoid arthritis. | Drugs | 1986 | https://conductscience.org/library/papers/2877858 | PubMed |
| 2,877,854 | Variables affecting efficacy and toxicity of sulphasalazine in rheumatoid arthritis. A review. | Drugs | 1986 | https://conductscience.org/library/papers/2877854 | PubMed |
| 2,877,851 | 5-Aminosalicylic acid or sulphapyridine. Which is the active moiety of sulphasalazine in rheumatoid arthritis? | Drugs | 1986 | https://conductscience.org/library/papers/2877851 | PubMed |
| 2,877,850 | Pharmacological and biochemical actions of sulphasalazine. | Drugs | 1986 | https://conductscience.org/library/papers/2877850 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CRP | 1,401 | PubTator's text mining | https://conductscience.org/library/genes/1401 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28650
GET https://conductscience.org/api/papers/v1/28650/cited_by?page=2